This content is machine translated Adherence in Cystic Fibrosis (CF) Techniques of motivational interviewing (MI) Important developments in CF treatment and management strategies have led to improvements in the health status of people with this disease. It is widely recognized that survival is improving, at… CME-Test
View Post 5 min This content is machine translated medizinonline Long-term data on upadacitinib show a consistent safety profile and no new safety signals [1].
View Post 11 min This content is machine translated IBD matters: Module four Molecular mechanisms in pathogenesis and treatment. Studies have shown that altered immune cell transport and pathogenic immune cells are critical factors responsible for mucosal inflammation and tissue destruction in IBD. A defective intestinal barrier and microbial… CME-Test
View Post 13 min This content is machine translated Chronic inflammatory bowel disease Treatment options for vulnerable patient populations Vulnerable patient populations with inflammatory bowel disease (IBD) require individualized and advanced treatment options. For example, the proportion of childless individuals with IBD is increased, often due to inadequate information… CME-Test
View Post 1 min This content is machine translated Swiss Oncology in Motion Special “GENETIC INSTABILITY” In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med.… CME-Test
View Post 1 min This content is machine translated Podcast JAK inhibitors in inflammatory rheumatic diseases. Thanks to the development of advanced therapies, the goal of remission is within reach for more and more patients with inflammatory rheumatic diseases [1]. In the following podcast, Prof. Stephan…
View Post 12 min This content is machine translated Parkinson's disease Optimization of L-dopa therapy at the onset of effect fluctuations. Levodopa is still considered the gold standard in the treatment of Parkinson’s disease. Among them, good symptom control with a high quality of life can be achieved for the patient… CME-Test
View Post 12 min This content is machine translated Parkinson's disease Optimization of L-dopa therapy at the onset of effect fluctuations Levodopa is still considered the gold standard in the treatment of Parkinson’s disease. Among them, good symptom control with a high quality of life can be achieved for the patient… CME-Test
View Post 15 min This content is machine translated New oral therapy for ulcerative colitis First selective S1P receptor modulator in gastroenterology Ozanimod offers a new treatment option for adult patients with moderate to severe active ulcerative colitis (UC) who have had an inadequate or no response to conventional therapy or a… CME-Test
View Post 13 min This content is machine translated Multiple sclerosis S1P receptor modulators in RRMS: tailored therapy management Modulation of S1P receptors is an important and interesting therapeutic target in the treatment management of multiple sclerosis due to their functional multifold. Currently, three S1P receptor modulators are available… CME-Test
View Post 1 min This content is machine translated Advanced training Launch event for interdisciplinary training on new treatment in ulcerative colitis On 01.09.2022 the interdisciplinary training on the treatment of ulcerative colitis incl. Discussion panel chaired by Prof. Dr. med. Dr. phil. Gerhard Rogler takes place. Registration for participation in the…
